The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy

Clin Endocrinol (Oxf). 2002 Sep;57(3):401-4. doi: 10.1046/j.1365-2265.2002.01549.x.

Abstract

TSH-secreting pituitary tumours are rare but difficult to treat due to a combination of refractory hyperthyroidism and low surgical cure rates. We describe the case of a 21-year-old woman who, despite twin pregnancy, became euthyroid and had dramatic tumour shrinkage on octreotide treatment. To our knowledge, this is the first description of the use of octreotide for a TSH-secreting pituitary adenoma throughout pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Adenoma / drug therapy*
  • Adenoma / metabolism
  • Adult
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Female
  • Humans
  • Octreotide / therapeutic use*
  • Pituitary Neoplasms / drug therapy*
  • Pituitary Neoplasms / metabolism
  • Pregnancy
  • Pregnancy Complications, Neoplastic / drug therapy*
  • Thyrotropin / metabolism*
  • Twins

Substances

  • Antineoplastic Agents, Hormonal
  • Thyrotropin
  • Octreotide